Companies to watch: These three biotech startups are in clinical trials

This piece is presented by South Dakota Biotech.

Three companies with a huge range of promising technologies will be part of a panel discussion June 15 at Breakthrough, an annual summit and banquet for South Dakota Biotech.

To register, click here.

Here’s more about the cutting-edge work of these three companies, each of which is involved in clinical trials:

Dr. Myles Greenberg, CEO of Alucent.

Alumend is part of the Avera Research Institute and operates its applied research division in Sioux Falls. Alucent Medical Inc., a company owned by Alumend LLC, is licensed by Alumend to test and market Natural Vascular Scaffolding, which was developed by Alumend for peripheral vascular disease below the waist. Alucent Medical is conducting phase one human clinical trials for NVS, the first combination product for vascular medicine to progress through the FDA approval process.

Immutrix Therapeutics, Inc. develops and markets a blood-cleansing treatment device. The company’s product removes inflammatory mediators and toxins from blood using proprietary adsorbents and smart hollow-fiber membranes. The company was incorporated in 2009 and is based in Rapid City.

SAB Biotherapeutics Inc. (SAB), is a Sioux Falls biopharmaceutical company on the leading edge of innovation, developing and delivering natural technologies that have the potential to transform the prevention and treatment of diseases from Ebola to cancer, and diabetes to influenza. SAB’s first-of-its-kind therapeutic production platform holds the promise of treatment of rare conditions, long-term diseases and global pandemic threats.

“It’s exciting and encouraging to see the promising innovation occurring within South Dakota companies,” said Joni Johnson, South Dakota Biotech’s executive director. “We look forward to hearing more about what’s next for them at Breakthrough.”

Companies to watch: These three biotech startups are in clinical trials

Three companies with a huge range of promising technologies will be part of a panel discussion June 15 at Breakthrough, an annual summit and banquet for South Dakota Biotech.

News Tip

Have a business news item to share with us?

Scroll to top